Permeation of quinine across sublingual mucosa, in vitro

International Journal of Pharmaceutics

Volumn 366, Issue 1-2, 2009, Pages 58-64

  Ong, Charlene M Y ^a   Heard, Charles M ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Leg cramps; Malaria; Quinine; Sublingual; Tongue

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; QUININE;

ANIMAL TISSUE; ARTICLE; COMPLEX FORMATION; DIFFUSION; DRUG DELIVERY SYSTEM; DRUG PENETRATION; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SALIVA; SUBLINGUAL GLAND; SWINE;

ADMINISTRATION, SUBLINGUAL; ANIMALS; ANTIMALARIALS; BETA-CYCLODEXTRINS; CHEMISTRY, PHARMACEUTICAL; CHILD; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG CARRIERS; HUMANS; MOUTH MUCOSA; PERMEABILITY; QUININE; SALIVA; SWINE; TONGUE;

EID: 57849090000     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2008.08.048     Document Type: Article

References (51)

1. Babu R.J., Kanikkannan N., Kikwai L., Ortega C., Andega S., Ball K., Yim S., and Singh M. The influence of various methods of cold storage of skin on the permeation of melatonin and nimesulide. J. Contr. Rel. 86 (2003) 49-57
2. British National Formulary 54, 2007.
3. Chen L.-L.H., Chetty D.J., and Chien Y.W. A mechanistic analysis to characterize oramucosal permeation properties. Int. J. Pharm. 184 (1999) 63-72
4. Cole L., and Heard C. Skin permeation enhancement potential of aloe vera and a proposed mechanism of action based upon size exclusion and pull effect. Int. J. Pharm. 333 (2007) 10-16
5. Collins L.M.C., and Dawes C. The surface area of the adult human mouth and thickness of the salivary film covering the teeth and oral mucosa. J. Dent. Res. 66 (1987) 1300-1302
6. Consonni R., Recca T., Dettori M.A., Fabbri D., and Delogu G. Structural characterization of imazalil/cyclodextrin inclusion complex. J. Agric. Food Chem. 52 (2004) 1590-1593
7. Ducharme A., Dupuis J., McNicoll S., Harel F., and Tardif J.-C. Comparison of nitroglycerin lingual spray and sublingual tablet on time of onset and duration of brachial artery vasodilation in normal subjects. Am. J. Cardiol. 84 (1999) 952-954
8. Fawaz F., Koffi A., Guyot M., and Millet P. Comparative in vitro-in vivo study of two quinine rectal gel formulations. Int. J. Pharm. 280 (2004) 151-162
9. Flanagan K.L., Buckley-Sharp M., Doherty T., and Whitty C.J.M. Quinine levels revisited: the value of routine drug level monitoring for those on parenteral therapy. Acta Trop. 97 (2006) 233-237
10. Ganem-Quintanar A., Kalia Y.M., Falson-Rieg F., and Buri P. Mechanisms of oral permeation enhancement. Int. J. Pharm. 156 (1997) 127-142
11. Ganem-Quintanar A., Quintanar-Guerrero D., Falson-Rieg F., and Buri P. Ex vivo oral mucosal permeation of lidocaine hydrochloride with sucrose fatty acid esters as absorption enhancers. Int. J. Pharm. 173 (1998) 203-210
12. Hall A.J. Cramp and salt balance in ordinary life. Lancet 3 (1947) 231-233
13. Heaney T.G., and Jones R.S. Histological investigation of the influence of adult porcine alveolar mucosal connective tissue on epithelial differentiation. Arch. Oral Biol. 23 (1978) 713-717
14. Heard C.M., and Screen C. Probing the permeation enhancement of mefenemic acid by ethanol across full-thickness skin, heat-separated epidermal membrane and heat-separated dermal membrane. Int. J. Pharm. 349 (2008) 323-325
15. Huston M., and Levinson M. Are one or two dangerous? Quinine and quinidine exposure in toddlers. J. Emerg. Med. 31 (2006) 395-401
16. Jullian C., Miranda S., Zapata-Torres G., Mendizábal F., and Olea-Azar C. Studies of inclusion complexes of natural and modified cyclodextrin with (+) catechin by NMR and molecular modelling. Bioorgan. Med. Chem. 15 (2007) 3217-3224
17. Kikwai L., Kanikkannan R.J., Babu R.J., and Singh M. Effect of vehicles on the transdermal delivery of melatonin across porcine skin in vitro. J. Contr. Rel. 83 (2002) 307-311
18. Koffi A.A., Agnely F., Besnard M., Brou J.K., Grossiord J.L., and Ponchel G. In vitro and in vivo characteristics of a thermogelling and bioadhesive delivery system intended for rectal administration of quinine in children. Eur. J. Pharm. Biopharm. 69 (2008) 167-175
19. Kurosaki Y., Yano K., and Kimura T. Perfusion cells for studying regional variation in oral mucosal permeability in humans. 2. A specialized transport mechanism in d-glucose absorption exists in dorsum of tongue. J. Pharm. Sci. 87 (1998) 613-615
20. Lalloo D.G., Shingadia D., Pasvol G., Chiodini P.L., Whitty C.J., Beeching N.J., Hill D.R., Warrell D.A., and Bannister B.A. UK malaria treatment guidelines. J. Infect. 54 (2007) 111-121
21. Lentner C. Geigy scientific tables volume 3. Physical Chemistry Composition of Blood Haematology Somatometric Data. eighth ed. (1984), Ciba-Geigy Limited, Basel, Switzerland
22. Lesch C.A., Squeir C.A., Cruchley A., Williams D.M., and Speight P. The permeability of human oral mucosa and skin to water. J. Dent. Res. 68 (1989) 1345-1349
23. Loftsson T., and Duchêne D. Cyclodextrins and their pharmaceutical applications. Int. J. Pharm. 329 (2007) 1-11
24. Man-Son-Hing M., and Wells G. Meta-analysis of efficacy of quinine for treatment of nocturnal leg cramps in elderly people. BMJ 310 (1995) 13-17
25. Man-Son-Hing M., Wells G., and Lau A. Quinine for nocturnal leg cramps: a meta-analysis including unpublished data. J. Gen. Intern. Med. 13 (1998) 600-606
26. Marmor A. Comparative evaluation of a new formulation of isosorbide dinitrate oral spray and sublingual nitroglycerin tablets. Am. J. Cardiol. 65 (1990) 43J-45J
27. Noonan P.K., and Benet L.Z. Incomplete and delayed bioavailability of sublingual nitroglycerin. Am. J. Cardiol. 55 (1985) 184-187
28. Oh H.-J., Oh Y.-K., and Kim C.-K. Effects of vehicles and enhancers on transdermal delivery of melatonin. Int. J. Pharm. 212 (2001) 63-71
29. Parker J.O., Vankoughnett K.A., and Farrell B. Nitroglycerin lingual spray: clinical efficacy and dose-response relation. Am. J. Cardiol. 57 (1986) 1-5
30. 1H NMR study and photolysis. J. Photochem. Photobiol. A 161 (2004) 261-267
31. Raes A., Van Aken S., Craen M., Donckerwolcke R., and Vande Walle J. A reference frame for blood volume in children and adolescents. BMC Paediatrics 6 (2006)
32. Rathbone M.J., Ponchel G., and Ghazali F.A. Systemic oral mucosal drug delivery and delivery systems. In: Rathbone M.J. (Ed). Oral Mucosal Drug Delivery (1996), Marcel Dekker, Inc., New York
33. Reisin L.H., Landau E., and Darawshi A. More rapid relief of pain with isosorbide dinitrate oral spray than with sublingual tablets in elderly patients with angina pectoris. Am. J. Cardiol. 61 (1988) 2E-3E
34. Rossi S., Sandri G., and Caramella C.M. Buccal drug delivery: a challenge already won?. Drug Discov. Today: Technol. 2 (2005) 59-65
35. Salehian B., Wang C., Alexander G., Davidson T., McDonald V., Berman N., Dudley R.E., Ziel F., and Swerdloff R.S. Pharmacokinetics, bioefficacy, and safety of sublingual testosterone cyclodextrin in hypogonadal men: comparison to testosterone enanthate-a clinical research center study. J. Clin. Endocrin. Metab. 80 (1995) 3567-3575
36. Squier C.A., and Johnson N.W. Permeability of oral mucosa. Br. Med. Bull. 31 (1975) 169-175
37. Squier C.A., and Hall B.K. In vitro permeability of porcine oral mucosa after epithelial separation, stripping and hydration. Arch. Oral Biol. 30 (1985) 485-491
38. Squier C.A., and Hall B.K. The permeability of skin and oral mucosa to water and horseradish peroxidase as related to the thickness of the permeability barrier. J. Invest. Dermatol. 84 (1985) 176-179
39. Squier C.A., and Nanny D. Measurement of blood flow in the oral mucosa and skin of the Rhesus monkey using radiolabelled microspheres. Arch. Oral Biol. 30 (1985) 313-318
40. Squier C.A. The permeability of oral mucosa. Crit. Rev. Oral Biol. Med. 2 (1991) 13-32
41. Squier C.A., Cox P., and Wertz P.W. Lipid content and water permeability of skin and oral mucosa. J. Invest. Dermatol. 96 (1991) 123-126
42. Squier C.A., and Wertz P.W. Structure and function of the oral mucosa and implications for drug delivery. In: Rathbone M.J. (Ed). Oral Mucosal Drug Delivery (1996), Marcel Dekker, Inc., New York
43. Sudhakar Y., Kuotsu K., and Bandyopadhyay A.K. Buccal bioadhesive drug delivery-a promising option for orally less efficient drugs. J. Contr. Rel. 114 (2006) 15-40
44. Szejtli J., and Szente L. Elimination of bitter, disgusting tastes of drugs and foods by cyclodextrins. Eur. J. Pharm. Biopharm. 61 (2005) 115-125
45. Ungphaiboon S., and Maitani Y. In vitro permeation studies of triamcinolone acetonide mouthwashes. Int. J. Pharm. 220 (2001) 111-117
46. Wang X.-M., and Chen H.-Y. Investigation of the β-cyclodextrin-quinine inclusion complex in aqueous solution by spectroscopic study. Spectrochim. Acta 51A (1995) 333-339
47. Wang Y., Chow M.S.S., and Zuo Z. Mechanistic analysis of pH-dependent solubility and trans-membrane permeability of amphoteric compounds: application to sildenafil. Int. J. Pharm. 352 (2008) 217-224
48. Weatherell J.A., Robinson C., and Rathbone M.J. The flow of saliva and its influence on the movement deposition and removal of drugs administered to the oral cavity. In: Rathbone M.J. (Ed). Oral Mucosal Drug Delivery (1996), Marcel Dekker, Inc., New York
49. Williams A.C. Topical and transdermal drug delivery (2003), Pharmaceutical Press, London
50. WHO, 2007. Malaria. Fact Sheet No. 94.
51. Zhang H., Zhang J., and Streisand J.B. Oral mucosal drug delivery clinical pharmacokinetics and therapeutic applications. Clin. Pharmacokin. 41 (2002) 661-680